Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna Neuberg

Showing results (191-200 of 354) with videos related to

Pageof 36
Sort By:
British Journal of Haematology|September 4, 2010
Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridizationSunita R Setlur, Chunhwa Ihm, Joelle Tchinda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter studyJeffrey I Zwicker, Adam Rojan, Federico Campigotto, et al.
Oncoimmunology|November 22, 2012
Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patientsAna Brusic, Ursula Hainz, Martha Wadleigh, et al.
The New England Journal of Medicine|January 10, 2003
Community-based therapy for multidrug-resistant tuberculosis in Lima, PeruCarole Mitnick, Jaime Bayona, Eda Palacios, et al.
Cancer Research|September 5, 2002
Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine modelRichard LeBlanc, Laurence P Catley, Teru Hideshima, et al.
Haematologica|September 17, 2013
Impact of promoter polymorphisms in key regulators of the intrinsic apoptosis pathway on the outcome of childhood acute lymphoblastic leukemiaRocio Sanchez, Janick St-Cyr, Marie-Eve Lalonde, et al.
Leukemia Research|December 5, 2003
Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivoJonathan W Friedberg, Danielle A Dong, Sigui Li, et al.
British Journal of Haematology|April 7, 2009
A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomasJennifer R Brown, Jonathan W Friedberg, Yang Feng, et al.
American Journal of Hematology|October 9, 2018
Characteristics of myeloproliferative neoplasms in patients exposed to ionizing radiation following the Chernobyl nuclear accidentLarysa Poluben, Maneka Puligandla, Donna Neuberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapyJohn G Gribben, David P Ryan, Richard Boyajian, et al.
Pageof 36

Showing results (191-200 of 354) with videos related to

Sort By:
Pageof 36
British Journal of Haematology|September 4, 2010
Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridizationSunita R Setlur, Chunhwa Ihm, Joelle Tchinda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter studyJeffrey I Zwicker, Adam Rojan, Federico Campigotto, et al.
Oncoimmunology|November 22, 2012
Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patientsAna Brusic, Ursula Hainz, Martha Wadleigh, et al.
The New England Journal of Medicine|January 10, 2003
Community-based therapy for multidrug-resistant tuberculosis in Lima, PeruCarole Mitnick, Jaime Bayona, Eda Palacios, et al.
Cancer Research|September 5, 2002
Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine modelRichard LeBlanc, Laurence P Catley, Teru Hideshima, et al.
Haematologica|September 17, 2013
Impact of promoter polymorphisms in key regulators of the intrinsic apoptosis pathway on the outcome of childhood acute lymphoblastic leukemiaRocio Sanchez, Janick St-Cyr, Marie-Eve Lalonde, et al.
Leukemia Research|December 5, 2003
Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivoJonathan W Friedberg, Danielle A Dong, Sigui Li, et al.
British Journal of Haematology|April 7, 2009
A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomasJennifer R Brown, Jonathan W Friedberg, Yang Feng, et al.
American Journal of Hematology|October 9, 2018
Characteristics of myeloproliferative neoplasms in patients exposed to ionizing radiation following the Chernobyl nuclear accidentLarysa Poluben, Maneka Puligandla, Donna Neuberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapyJohn G Gribben, David P Ryan, Richard Boyajian, et al.
Pageof 36